Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, February 06, 2018
HemaCare and Charles River Laboratories have formed a partnership to advance human immune system research by developing a more efficient and reliable method of working with humanized mice.
read more
Wednesday, October 19, 2016
Hemispherx Biopharma has completed its technology transfer of the Ampligen® manufacturing processes to Avrio Biopharmaceuticals. The transfer consists of providing Avrio with all information that is relevant to the manufacturing process of Ampligen® ...
read more
Hemispherx Biopharma has reached an agreement with Avrio Biopharmaceuticals, Irvine California, to serve as an additional contract manufacturer of Hemispherx’s experimental drug, Ampligen®, also known by its generic name rintatolimod.
read more
Shanghai Henlius Biotech announced the company's drug substance line and drug product line for trastuzumab biosimilar have passed the EU GMP on-site inspection.
read more
Heptares Therapeutics announced the launch of a new research collaboration under its ORBIT initiative with New York University School of Medicine.
read more
Heptares Therapeutics announced its plans to relocate to a new facility at Granta Park, Cambridge, UK.
read more
Heptares has been notified by Teva a preclinical candidate calcitonin gene-related peptide antagonist has been nominated for advancement as an investigational treatment for migraine.
read more
Heptares Therapeutics, a wholly owned subsidiary of Sosei Group Corporation announced that it has entered into a drug discovery and licensing agreement with Daiichi Sankyo Company, Limited focused on a single G protein-coupled receptor (GPCR) ...
read more
Wednesday, April 05, 2017
Heptares Therapeutics , a wholly owned subsidiary of Sosei Group Corporation, has achieved an important milestone in its immuno-oncology collaboration with AstraZeneca, which is focused on the development of AZD4635 (HTL-1071) as a potential new ...
read more
Heraeus Pharmaceutical Ingredients’ additional production line for Platinum-based highly potent active pharmaceutical ingredients (Pt hAPIs) is now fully operational at the company’s headquarters in Hanau, Germany. Heraeus, a business line of Heraeus...
read more
Friday, November 22, 2019
Heraeus Pharmaceutical Ingredients has expanded its capacity for Platinum-based highly potent active pharmaceutical ingredients with an additional production line built at the company’s headquarters in Hanau, Germany.
read more
Wednesday, April 10, 2019
HERMA GmbH has moved its Labeling Machinery Division to a new state-of-the-art facility at its headquarters site in Filderstadt, Germany.
read more
HERMES PHARMA, previously a division of HERMES Arzneimittel GmbH, announced a separate legal entity named HERMES PHARMA GmbH. The forward-looking change will see both HERMES PHARMA GmbH and HERMES Arzneimittel GmbH operating independently but ...
read more
Wednesday, October 19, 2016
Hermes Pharma, a leader in user-friendly oral dosage forms, has announced the availability of a new desiccant stopper. The patent-protected stopper features a two-step, easy-opening technique suitable for multi-dose tablet tube containers.
read more
Hetero has entered into a licensing agreement with Gilead Sciences for the manufacturing and distribution of Remdesivir for the treatment of Covid-19.
read more